Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08ZSJ
|
|||
| Drug Name |
VX-880
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Type-1 diabetes [ICD-11: 5A10] | Phase 1/2 | [1] | |
| Company |
Vertex Pharmaceuticals Boston, MA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04786262) A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-880 in Subjects Who Have Type 1 Diabetes Mellitus With Impaired Hypoglycemic Awareness and Severe Hypoglycemia. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.